R.M. Ore

Symptoms Relevant to Surveillance for Ovarian Cancer

To examine how frequently and confidently healthy women report symptoms during surveillance for ovarian cancer. A symptoms questionnaire was administered to 24,526 women over multiple visits accounting for 70,734 reports. A query of reported confidence was included as a confidence score (CS). Chi square, McNemars test, ANOVA and multivariate analyses were performed. 17,623 women completed the symptoms questionnaire more than one time and >9500 women completed it more than one four times for >43,000 serially completed questionnaires. Reporting ovarian cancer symptoms was ~245 higher than ovarian cancer incidence. The positive predictive value (0.073%) for identifying ovarian cancer based on symptoms alone would predict one malignancy for 1368 cases taken to surgery due to reported symptoms. Confidence on the first questionnaire (83.3%) decreased to 74% when more than five questionnaires were completed. Age-related decreases in confidence were significant (p < 0.0001). Women reporting at least one symptom expressed more confidence (41,984/52,379 = 80.2%) than women reporting no symptoms (11,882/18,355 = 64.7%), p < 0.0001. Confidence was unrelated to history of hormone replacement therapy or abnormal ultrasound findings (p = 0.30 and 0.89). The frequency of symptoms relevant to ovarian cancer was much higher than the occurrence of ovarian cancer. Approximately 80.1% of women expressed confidence in what they reported.

First year participation in the affordable care act: costs and accessibility to gynecologic oncology

With the ending of the operational first year of the American Affordable Care Act, health insurance premiums were accessed online. For a US

Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky

50,000 income, the lowest premiums ranged from US

Ultrasound surveillance of ovarian abnormalities characterized by stable morphology or morphologies changing between cysts, septated cysts, cysts with solid structure or solid structures

805 annually (age 20 years) to US

Pain persisting after the resolution of ovarian abnormalities

3802 (age 64 years), while the highest ranged from US

A report on the frequency of depression and anxiety in women with cancer by site

2186 (age 20 years) to US

Frequency of intimate partner violence history in gynecologic and breast cancers

10,326 (age 64 years). The lowest premiums at age 50 years were higher in rural areas in contrast to the highest premiums that were less expensive rurally. At age 64 years, the lowest premiums were 9–12.6% of a US

Comparing 2 sonographic scoring systems for distinguishing benign from malignant ovarian tumors

50,000 income, while the most expensive varied between 16.5 and 39%. Access to gynecologic oncologists was variable in different networks. Medicaid enrollment nationally was ∼6x higher than paid enrollment. Eligible participation in Affordable Care Act coverage exceeded expectations by >190%. Performance of four healthcare exchange traded funds indicated that investor confidence is high in the American healthcare sector.